thromboplastin and iberiotoxin

thromboplastin has been researched along with iberiotoxin* in 1 studies

Other Studies

1 other study(ies) available for thromboplastin and iberiotoxin

ArticleYear
Reversible inhibition of the platelet procoagulant response through manipulation of the Gardos channel.
    Blood, 2006, Oct-01, Volume: 108, Issue:7

    The platelet procoagulant response requires a sustained elevation of the intracellular Ca2+ concentration, [Ca2+]i, causing exposure of phosphatidylserine (PS) at the outer surface of the plasma membrane. An increased [Ca2+]i also activates Ca2+-dependent K+ channels. Here, we investigated the contribution of the efflux of K+ ions on the platelet procoagulant response in collagen-thrombin-activated platelets using selective K+ channel blockers. The Gardos channel blockers clotrimazol, charybdotoxin, and quinine caused a similar decrease in prothrombinase activity as well as in the number of PS-exposing platelets detected by fluorescence-conjugated annexin A5. Apamin and iberiotoxin, inhibitors of other K+ channels, were without effect. Only clotrimazol showed a significant inhibition of the collagen-plus-thrombin-induced intracellular calcium response. Clotrimazol and charybdotoxin did not inhibit aggregation and release under the conditions used. Inhibition by Gardos channel blockers was reversed by valinomycin, a selective K+ ionophore. The impaired procoagulant response of platelets from a patient with Scott syndrome was partially restored by pretreatment with valinomycin, suggesting a possible defect of the Gardos channel in this syndrome. Collectively, these results provide evidence for the involvement of efflux of K+ ions through Ca2+-activated K+ channels in the procoagulant response of platelets, opening potential strategies for therapeutic interventions.

    Topics: Annexin A5; Apamin; Blood Coagulation Factors; Blood Platelets; Calcium; Cell Membrane; Charybdotoxin; Clotrimazole; Humans; Ionophores; Peptides; Phosphatidylserines; Potassium; Thromboplastin; Valinomycin

2006